Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
Date:3/3/2009

The NaviStar(R) RMT ThermoCool(R) Catheter was created by Biosense Webster, a Johnson & Johnson Company.

For more information about the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, visit www.stdavids.com.

For more information about Texas Cardiac Arrhythmia, visit www.TCAheart.com.

    MEDIA CONTACTS:
    Kristin Marcum or Erin Ochoa
    Elizabeth Christian & Associates Public Relations
    512.472.9599


'/>"/>
SOURCE Texas Cardiac Arrhythmia Institute
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Motor behavioral research at UH moves to prestigious Texas Medical Center
2. New Texas Study Reveals Serious Flaws in Abstinence Programs
3. Texas Association of Health Underwriters Announces 15th Annual Day at the Capitol
4. Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession
5. University of Texas engineers receive $3.2 million in National Science Foundation CAREER awards
6. Accordent Delivers Medical Lecture Capture Platform for University of Texas Health Sciences Center
7. Texas Mutual Wins National Employee Wellness Award
8. New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia
9. Texas Health Dallas New Intensivist Program Puts Critical-Care Specialists in the ICU - All the Time
10. High-tech Texas hospitals see fewer complications, lower costs, UT Southwestern researcher finds
11. Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 CareTech Solutions ( www.CareTech.com ), an ... for hospitals and health systems, was named Best in ... 2009 Top 20 Best in KLAS Awards: Software ... ranks the performance of vendors in key market segments ... ,, CareTech,s overall performance score was 90.3 ...
(Date:12/17/2009)... M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null genotypes ... The results regarding the association between GSTM1 and GSTT1 ... were contradictory. However, the majority of previous reports are ... of the GSTM1/GSTT1 null genotype with the risk of ... with larger numbers of samples. , A research ...
(Date:12/17/2009)... As the UN Climate Conference in Copenhagen approaches ... of forests in mitigating climate change. The new ... has gained widespread support as a central element ... for almost 20% of global greenhouse gas emissions, ... make a major contribution to emissions reduction. Linked ...
(Date:12/17/2009)... the aging inequity , , THURSDAY, Dec. 17 ... gender inequity: Women develop more and deeper wrinkles ... do. , The disadvantage had long been suspected, ... said Dr. Foad Nahai, a plastic surgeon practicing ... Surgery Journal . The study appears in the ...
(Date:12/17/2009)... - Procedure Provides Efficient Mechanism to Pursue ... QC, Dec. 17 /PRNewswire-FirstCall/ - Labopharm Inc. ... announced it has initiated the regulatory approval ... Europe under the Decentralized Procedure (DCP). The ... a company to simultaneously pursue regulatory approval ...
Breaking Medicine News(10 mins):Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3Health News:Forests take center stage at Copenhagen 2Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3
... May 14 Quark Pharmaceuticals, Inc., a development-stage ... (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., ... "siRNA Therapeutics for Prevention of Ocular and Inner ... Nucleic Acid Diagnostics & Therapeutics. The event was ...
... for Consumers KANSAS CITY, Mo., May 14 ... 8.5 percent,(1) families are living on tighter budgets, and ... Despite these challenges, there are still ways for consumers ... to the National Association of Insurance Commissioners (NAIC). "These ...
... Corporation (Pink Sheets: CGCP) the "Company", a leading developer ... suffering from severe angina, today reported financial results for ... Financial ResultsNet revenues in the first quarter of 2009 ... first quarter net revenues of $2,982,000. During the ...
... New Research on Antioxidant-Enhanced SuncareKENILWORTH, N.J., May 14 ... SGP ), introduces COPPERTONE (R) , ... a new line of sunscreens enriched with antioxidants ... harmful free radicals created by UV exposure. ...
... convenience and broader access to an effective treatment ... frequent heartburn - Once-daily, prescription-strength Prevacid(R) 24HR is ... the treatment of frequent heartburn in the US ... heartburn for a full 24 hours BASEL, Switzerland, ...
... Significantly Impacted After Breaking a BoneSpecial Council of ... to Make Bone Health a Priority Before They ... Know My Bones Council today announced results ... that one-out-of-five women with postmenopausal osteoporosis (PMO) are ...
Other Medicine News:Health News:Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage 2Health News:Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage 3Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 2Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 3Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 4Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 5Health News:Cardiogenesis Reports First Quarter 2009 Results 2Health News:Cardiogenesis Reports First Quarter 2009 Results 3Health News:Cardiogenesis Reports First Quarter 2009 Results 4Health News:Cardiogenesis Reports First Quarter 2009 Results 5Health News:Cardiogenesis Reports First Quarter 2009 Results 6Health News:Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair 2Health News:Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair 3Health News:Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation 2Health News:Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation 3Health News:Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation 4Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 2Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 3Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 4Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 5Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 6Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 7Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 8Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 9
(Date:12/16/2009)... Incorporated (Nasdaq: ARAY ), a global leader in ... and chief executive officer, Euan S. Thomson, Ph.D., is ... Healthcare Conference in San Francisco on Wednesday, January 13, ... A live webcast of each presentation will be available ... Web site at http://www.accuray.com . The webcast ...
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), a technology ... solutions for the clinical trials industry, today ... eClinical Software. This release advances the ... delivery and introduces two new mechanisms for ... Learning Center(TM) and the DATATRAK Learning Manager(TM). ...
(Date:12/16/2009)... CINCINNATI, Dec. 16 HealthWarehouse.com, Inc. (OTC Bulletin ... it had secured $1 million in 12% per annum ... debt facility is an initial drawdown of $500,000, with ... second drawdown of $500,000 with accrued interest and principal ... to the Company becoming cashflow positive for any calendar ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2Most Parents Worried About Bullying in U S High Schools 56990 1Most Parents Worried About Bullying in U S High Schools 56990 2Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I V Automation Strategic Partnersh 56987 1Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I V Automation Strategic Partnersh 56987 2Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I V Automation Strategic Partnersh 56987 3Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting 4979 1Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting 4979 2Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting 4979 3
... Tecans MiniPrep series of robotic workstations ... The MiniPrep is the ideal automation ... automation of routine laboratory procedures, improving throughput, ... based Gemini for MiniPrep software allows you ...
... QFill2 is the ideal system for fast, accurate ... pressure driven, pinch valve controlled dispensing mechanism, ensures ... all of the components that come into contact ... clean, and autoclave. The unique compact design saves ...
... Automatic dispenser for low volumes. Dispenses ... 1536 -well format. Fast throughput of less ... productivity. The dispenser features an intuitive user ... be used to dispense liquids and suspensions, ...
... low volumes. Dispenses volumes down to 0.5ul ... throughput of less than 30 seconds per ... an intuitive user interface that provides one-button ... liquids and suspensions, beads, or cells, with ...
Medicine Products: